When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CureVac B.V. (CVAC) has filed to raise $100 million in an IPO of its common shares, according to an F-1 registration statement.
The firm is developing a wide range of treatments, vaccines and therapies based on messenger RNA technologies.
CVAC has developed extensive collaborations with major pharma firms and top tier research organizations.
I’ll provide a final opinion when we learn more about the IPO from management.
Company & Technology
Tubingen, Germany-based CureVac was founded to create mRNA-mediated treatment options for cancers, viral diseases including Covid-19 and gene editing-based protein